A series of inflammatory responses caused by Mycoplasma pneumoniae largely depend on the lipid-associated membrane proteins (LAMPs). Nuclear factor E2-related factor 2 (Nrf2), a transcription factor, is considered to be a critical modulator of inflammatory responses and cellular redox homeostasis. Monocytes play an important role in the invasion and immunity to resist pathogens. Here, we investigated the role of Nrf2 in the anti-inflammatory response stimulated by LAMPs using the human monocyte cell line THP-1. LAMPs were shown to affect the localization of Nrf2, and the levels of reactive oxygen species and inflammatory reactants, including nitric oxide (NO), prostaglandin E2 (PGE 2 ) and cytokines (IL-6, IL-8), were highly elevated in LAMP-stimulated Nrf2-silenced THP-1 cells. Moreover, LAMPs induced the levels of mRNA and the expression of heme oxygenase-1 (HO-1). In summary, our results demonstrated that LAMPs cause nuclear translocation of Nrf2, which further suppresses the expression of inflammatory reactants in THP-1 cells.
INTRODUCTION
Mycoplasmas are parasitic bacteria without cell walls and they are capable of self-replication (Muhlradt et al. 1997; Rawadi et al. 1998; Rawadi 2000; Zeng et al. 2004; Nakao et al. 2005) . Mycoplasma pneumoniae is an important pathogen of community-acquired pneumonia (CAP) and is also the cause of other respiratory tract infections. About 10%-30% of pneumonia cases are caused by M. pneumoniae (Gil et al. 1993; Beskind and Keim 1994; Chan et al. 1999; Tsiodras et al. 2005; Stamm et al. 2008) . Mycoplasma pneumoniae infection is usually slight, and is self-limiting to a certain degree. However, if it is not treated promptly, or immunocompromised people are infected, M. pneumoniae-derived CAP may lead to morbidity and mortality. The rate of severe CAP in patients who are hospitalized ranges from 6.6% to 16.7% (Ewig, Woodhead and Torres 2011) . Both the morbidity and mortality are significantly increased in patients with moderate-to-severe CAP, and mortality rates of seriously ill inpatients with CAP ranging from 5% to 30%-50% (Welte 2012) .
Due to the lack of cell walls, mycoplasmas interact with the host cells or the external environment through the cell membrane. And in particular, although the so-called lipidassociated membrane proteins (LAMPs) expressed on the surface, the lipoprotein components of the M. pneumoniae membrane represent a critical role in the host immune inflammatory response (Chmura et al. 2008) . LAMPs have been found to bind to Toll-like receptor (TLR) 1, 2 and 6 as well as CD-14 on monocytes /macrophages, which subsequently activate downstream interleukin-1R (IL-1R)-associated signal molecules, leading to the activation of nuclear factor-κB (NF-κB) and activating protein 1 (AP-1) (Shimizu, Kida and Kuwano 2005) . This process finally triggers the expression of proinflammatory cytokines, such as TNF-α, IL-1β, IL-6 and IL-8, as well as inflammatory mediators such as PGE 2 , ROS, NO and other bioactive substances (Muhlradt et al. 1997; Rawadi et al. 1998; Rawadi 2000; Zeng et al. 2004; Nakao et al. 2005) . In addition, a recent study found that LAMPs derived from M. hyorhinis contribute to activate the NLRP3 inflammasome and induce the expression of IL-1β (Xu et al. 2013) .
Nuclear factor E2-related factor 2 (Nrf2), a key transcription factor involves in the regulation of the anti-inflammatory response, is widely expressed in all human tissues. In general, Nrf2 is located in the cytoplasm and remains a low level by proteasome degradation via a Keap-1-dependent mechanism (Kobayashi et al. 2004) . Nrf2 translocates into the nucleus, then binds and activates anti-oxidant response element (ARE)-sequence-containing target genes, including GST, GPx, SOD, CAT, EPHX and heme oxygenase-1 (HO-1) (Nguyen, Huang and Pickett 2000; Narasimhan et al. 2014) . Nrf2 is widely regarded as a multiorgan protector owing to its anti-oxidative and cyto-protective functions (Baird and Dinkova-Kostova 2011; Bocci and Valacchi 2015) . It also participates in anti-inflammation damage and anti-UV damage repair processes (Tao et al. 2015) .
In this paper, we investigated whether Nrf2 regulates the inflammatory response initiated by LAMPs, and assessed the production of inflammatory reactants in the human monocyte cell line THP-1 after silencing of Nrf2.
MATERIALS AND METHODS

Materials
General laboratory reagents and plastics were purchased from Invitrogen (Carlsbad, CA, USA). All media and buffers were obtained from Corning. Cytokines were acquired from R&D Systems (Minneapolis, MN, USA). Real-time PCR primers, Nrf2 shRNA and negative-control shRNA were synthesized by Invitrogen. pLKO.1-Nrf2 shRNA lentiviral vectors were obtained from GenePharma (Shanghai, CN). Antibodies were produced in Cell Signaling Technology (Boston, MA, USA). Horseradish peroxidase (HRP)-labeled secondary antibodies (goat anti-rabbit IgG and goat anti-mouse IgG) and polyvinylidenedifluoride (PVDF) membranes were purchased from Millipore (Billerica, MA, USA). Endotoxin-free consumables were obtained from Axygen (Silicon Valley, CA, USA) and Gilson (Madison, WI, USA).
Mycoplasma growth and extraction of LAMPs
Mycoplasma pneumoniae (strain M129, ATCC 29342) was grown in PPLO broth at 37
• C in an incubator for 5-7 days and harvested when the red pH indicator turned orange. An M. pneumoniae pellet obtained by centrifugation (14000 rpm/20 min) of a 1-L culture was resuspended in 10 mL Tris-buffered saline (TBS: 50 mM Tris pH 8.0, 0.15 M NaCl) containing 1 mM EDTA (TBSE), solubilized by adding Triton X-114 to a final concentration of 2%, and incubated at 4
• C for 1 h. To prepare LAMPs, the Triton X-114 lysate was incubated at 37
• C for 10 min to allow phase separation. The upper aqueous phase was removed and replaced with the same volume of TBSE. The solution was then incubated at 4
• C for 10 min, and the procedures for phase fractionation were repeated twice. The final Triton X-114 phase was resuspended in TBSE at 4
• C to the original volume, and 2.5 volumes of ethanol was added to precipitate proteins at -20 • C for 12 h. After centrifugation at 14 000 rpm for 20 min, the pellet was resuspended in phosphate-buffered saline (PBS) by sonication (3 min).
Cell culture and lentiviral shRNA transduction for gene silencing
Cells were grown in complete medium (THP-1: RPMI-1640 plus 10% fetal bovine serum (FBS)) and incubated at 37
• C in a humidified incubator containing 5% CO 2 . pLKO.1-Nrf2 shRNA, which contains the human Nrf2-specific shRNA (5 -CCGGTCCCGTTTGTAGATGACAACTCGAGTTGTCATCTACAAACG-GGATTTTTG-3 ), and the packaging mix were transfected into HEK 293T cells using Lipofectamine 2000 (Invitrogen). The pLKO.1-scRNA (negative-shRNA) plasmid was used to generate a non-specific control RNA. After 48 h, transfection complexes were replaced by complete medium. Media containing lentiviral particles were harvested after 4 days. THP-1 cells were plated in six-well plates at 37
The next day, polybrene was added at a concentration of 8 μg/mL and 500 μL viral particles to each well. Following a day, viral particles can be replaced with fresh medium containing puromycin.
RNA extraction and real-time PCR
Total RNAs were extracted from cells using Trizol reagent (Invitrogen). Reverse transcription of 3 μg total RNA was performed according to the instructions of Fermentas Life Sciences. Sequences of primers were as follows:
Real-time PCR amplification was done in 384-well plates in a final volume of 10 μL containing 5 μL qPCR mix, 2 mL of a 7.5 μM solution of the respective primers and 1 μL reverse-transcribed RNA. The thermal cycling was done at 95
• C for 10 min followed by 40 PCR cycles at 95
• C for 15 s and 60
• C for 1 min. The mRNA levels of targeted genes were calculated using GAPDH as normalization control. Ct was used to calculate relative amplification of each transcript.
Western blotting
THP-1 cells were collected by centrifugation (1000 rpm, 5 min) and rinsed twice with PBS, after which protein extracts were obtained by lysis with protease inhibitor for 30 min and centrifugation at 12 000 rpm for 10 min at 4
• C. A portion of 20 μL protein extract was electrophoresed by SDS-polyacrylamide gel electrophoresis, and then transferred onto a polyvinylidene difluoride (PVDF) membrane in a semidry transblot apparatus. After rinsing three times with TBS, the PVDF membrane was incubated with buffer containing 5% non-fat dry milk in Trisbuffered saline with Tween (TBST) for 2 h. The PVDF membrane was then incubated with a 1:2000 polyclonal rabbit antibody (anti-Nrf2, anti-HO-1, anti-ACTB, anti-COX-2 or anti-iNOS, as appropriate) for 12 h at 4 • C. After washing three times with TBST, goat anti-rabbit IgG-HRP was added for 1 h at 37
• C. The protein bands were quantified by scanning gray values using GraphPad Prism software and were normalized against β-actin.
ELISA assay
LAMPs at different concentrations were used to stimulate Nrf2 shRNA lentivirus-infected cells, control lentivirus-infected cells or non-infected cells; PBS stimulation was used as a negative control group and lipopolysaccharide (LPS) stimulation as a positive control. Briefly, cells were plated into 24-well plates and incubated at 4
• C overnight. The diluted samples were distributed in each plate and incubated with anti-IL-6, IL-8 and PGE 2 horseradish peroxidase after washing. The concentrations of IL-6, IL-8 and PGE 2 in supernatants were measured using an ELISA kit. Results were presented as A 450.
Griess assay
NO was assayed by measuring the nitrite levels (resulting from NO metabolism). Supernatants were collected after stimulation with LAMPs, LPS and PBS. Nitrite production was determined by Griess reagent and a microplate reader.
ROS assay
Cells were seeded into 24-well plates. The redox-sensitive fluorescent dye DCFH-DA was used to estimate intracellular accumulation of ROS. Each group was incubated with 10 μM DCFH-DA at 37
• C for 20 min. Then these stained cells were washed three times and finally resuspended in PBS. Fluorescence intensity was measured using a fluorescence microplate reader (excitation 488 nm, emission 525 nm).
Statistical analyses
Data were analyzed using GraphPad Prism software. Results are means ± SD. Statistical significance for each group comparisons was assessed using one-way ANOVA. Multiple comparisons between the groups was performed using the S-N-K method. Values less than 0.05 were statistically significant.
RESULTS
LAMPs induce translocation of Nrf2 protein from cytoplasm to nucleus in THP-1 cells
To investigate whether LAMPs cause Nrf2 translocation, THP-1 cells were treated for 0-4 h with 5 μg/mL LAMPs, and then cytosolic and nuclear proteins were analyzed for Nrf2 expression by immunblotting and immunofluorescence assays (IFA). Nrf2 was predominantly localized in the cytoplasm in control cells, but shifted to the nucleus following stimulation with LAMPs ( Fig. 1A and C) . Upregulation of nuclear Nrf2 protein levels was Figure 1 . LAMPs induce nuclear translocation of Nrf2 in THP-1 cells. THP-1 cells were stimulated with 5.0 μg/mL LAMPs for various times and cytoplasmic and nuclear lysates were prepared and analyzed by western blotting (A). EMSA was performed with nuclear protein extracts at the time points shown (B). IFA shows transfer of cytoplasmic Nrf2 protein to the nucleus (C). Nrf2 (red) was found to localize in neurons after treated with LAMPs. 4 ,6-diamidino-2-phenylindole (DAPI, blue) for control. LAMPs were used to stimulate THP-1 cells infected with Nrf2 shRNA lentivirus or control lentivirus. PBS-stimulated group was used as a negative control. (A) Nrf2 protein levels determined by immunoblotting; (B) Nrf2 mRNA levels determined by qRT-PCR. Data represent means ± SD from at least three independent experiments. * P < 0.05 for a significant difference between the groups; #P < 0.05 for a significant difference within a group.
observed in cells during 4 h of treatment with LAMPs in a timedependent manner, but not in controls. The nuclear translocation of Nrf2 was further confirmed by EMSA studies (Fig. 1B) . Nrf2 DNA binding activity peaked at 120 min in LAMP-induced THP-1 cells. The results demonstrated that LAMPs are able to induce Nrf2 nuclear translocation in THP-1 cells.
LAMPs induce the expression of HO-1 via Nrf2 in THP-1 cells
Infection of THP-1 cells with Nrf2 shRNA lentivirus resulted in a 52.12% and 66.12% reduction in Nrf2 protein and mRNA levels following stimulation by LAMPs, respectively, compared to control cells (Fig. 2) . After treatment of Nrf2-silenced THP-1 cells and control cells with 5 μg/mL LAMPs, the expression of HO-1 was assessed by western blotting and qRT-PCR. As shown in Fig. 3A , HO-1 expression was lower in Nrf2-silenced THP-1 cells than that in controls. Accordingly, there was a clear reduction in HO-1 mRNA levels at the 6 and 9 h time points in Nrf2-silenced THP-1 cells (Fig. 3B) . These results indicated that Nrf2 regulates LAMP-induced HO-1 production.
Nrf2 negatively regulates LAMP-induced IL-6, IL-8 and ROS
Increased expression of inflammatory factors is one of the phenotypic characteristics of the inflammation. The treatment of LAMPs augmented proinflammatory cytokine IL-6 and chemokine IL-8 mRNA levels in a dose-dependent fashion. Notably, levels of these transcripts were significantly higher in Nrf2-silenced cells than those in the controls. To confirm that Nrf2-silenced cells also contained higher levels of the corresponding proteins, IL-6 and IL-8 levels were assessed by ELISA with THP-1 cell extracts ( Fig. 4A and B) . The results indicated that Nrf2 negatively regulates the expression of IL-6 and IL-8 following treatment with LAMPs. Additionally, the Nrf2-silenced cells showed higher levels of ROS: in a (A, B) ELISA of IL-6 and IL-8 levels following LAMP stimulation of Nrf2-silenced, control-silenced and untreated THP-1 cells, respectively. PBS (i.e. no LAMP treatment) was used as a negative control, LPS stimulation as a positive control. (C) ROS levels were determined using a fluorescent probe (DCFH-DA) assay. All values are expressed as means ± SD from three independent experiments. * P < 0.05 indicates a significant difference between the groups; #P < 0.05 indicates a significant difference within a group.
DCFH-DA assay, the fluorescent intensity of lentivirus Nrf2 shRNA-treated cells increased following LAMP stimulation, compared to the control lentivirus-treated cells and untreated cells, respectively (Fig. 4C) . Furthermore, while LAMP treatment led to an increase in expression of Nrf2, this was largely abolished in Nrf2-silenced cells.
Nrf2 inhibits the release of NO and PGE 2 by reducing the expression of iNOS and COX-2 in LAMP-stimulated THP-1 cells
To assess the anti-inflammatory activities of Nrf2, Nrf2-silenced, control-silenced and untreated THP-1 cells treated with LAMPs, the levels of nitrite, a stable metabolite of NO, and PGE 2 , an important inflammatory mediator, were measured in the medium. As shown in Fig. 5A and B, the accumulation of LAMP-inducible NO and PGE2 was higher after silencing Nrf2. To determine whether Nrf2 reduces NO and PGE 2 production resulting from LAMP treatment, we studied the effect of Nrf2 on iNOS and COX-2 protein expression in THP-1 cells by immunoblotting COX-2, an inducible form of cyclooxygenase which regulates endogenous prostaglandin synthesis. Increasing numbers of studies have demonstrated that COX-2-mediated pathways are vital in inflammatory reactions (Egyudova et al. 2012) . For example, in chronic obstructive pulmonary disease, cigarette smokeinduced COX-2 promotes to the proinflammatory effects of prostaglandin E2 (PGE2). In human placental trophoblast cells, the expression of COX-2 and production of PGE2 caused by MALP-2 may be involved in the mechanism of preterm labor (Egyudova et al. 2012) . As shown in Fig. 5C and D, iNOS and COX-2 protein expression were markedly increased in Nrf2-silenced cells compared to controls. These results indicated that the increase in the expression of iNOS and COX-2 was responsible for the elevated levels of NO and PGE 2 observed in Fig. 5A and B.
DISCUSSION
Inflammation is a fundamental innate immune response, resulting in a protective host response. However, after persistent infection, release of proinflammatory factors, ROS, NO and other bioactive substances can occur which skews the host response to 'hyperinflammation' with exaggerated tissue damage. So there must be some negative regulatory mechanism to regulate excessive inflammatory response. Inflammatory responses are modulated by some transcription factors and cellular signaling pathway (Prawan et al. 2009 ). The classical NF-κB pathway promotes the production of ROS and proinflammatory cytokines (Sundaresan et al. 2012 ). In contrast, Nrf2 has been regarded as a key nuclear transcription factor that senses oxidizing conditions and protects cells from oxidative stress and inflammation (Yan et al. 2014) . In endothelial cells, Nrf2 activation inhibits the expression of proinflammatory cytokine-induced adhesion molecules. Conversely, Nrf2-null macrophages show enhanced TNFα production and NF-κB activity (Sundaresan et al. 2012) and retain a high level of ROS, which results in amplification of TLR4 signaling and greater mortality (Guo and Ward 2007) . Furthermore, treatment with endotoxin leads to higher levels of TNFα and IL-6 expression in Nrf2-deficient mice than in wild-type mice (Prawan et al. 2009) . In this study, we found that LAMPs derived from Mycoplasma pneumoniae can activate Nrf2 protein translocation from the cytoplasm to the nucleus in THP-1 cells, and Nrf2 silencing can negatively regulate COX-2, iNOS, IL-6, IL-8, NO, PGE 2 and ROS expression in LAMP-stimulated THP-1 cells.
Studies have shown that many microbial cell wall products such as LPS, peptidoglycan and lipoprotein can activate macrophages to synthesize and secrete a series of inflammatory-related proteins (Henderson, Poole and Wilson 1996) . Mycoplasma has no cell wall but it has LAMPs that can interact with the surroundings and affect the host immune system. In placental trophoblast cells, LAMPs of M. genitalium Figure 5 . The influence of Nrf2 on NO, PGE2, iNOS and COX-2 production in THP-1 cells stimulated with M. pneumoniae LAMPs. Griess detection of NO production (A) and ELISA determination of PGE2 expression (B) in Nrf2-silenced, control-silenced and untreated cells, prior to 5, 7.5 or 10 μg/mL M. pneumoniae LAMP stimulation. PBS treatment acted as a negative control and LPS stimulation as a positive control. Western blot determination of iNOS (C) and COX-2 (D) protein in Nrf2-silenced and control-silenced cells, which were stimulated with 7.5 or 10 μg/mL M. pneumoniae LAMPs for 16 h, or with no stimulation as a blank control group. All values are expressed as mean ± SD of three independent experiments. * P < 0.05 indicates a significant difference between groups; #P < 0.05 indicates a significant difference within a group.
negatively regulate cytokine secretion by inducing HO-1 expression (He et al. 2015) . The membrane components of five lipoproteins from M. arginini can stimulate the release of IL-1β, TNF-α and IL-6 in human monocytes (Into et al. 2002) .
In monocytic cells, HO-1 is thought to mediate potent antiinflammatory response, possibly by limiting tissue injury and by modulating the inflammatory response (Rawadi et al. 1998) . In response to LPS, mononuclear phagocytes also synthesize intracellular cytoprotective protein HO-1to protect against excessive inflammatory responses (Rawadi et al. 1998) . Our present data also clearly demonstrate that LAMPs, such as LPS and MALP-2, induce the mRNA and protein expression of HO-1 in THP-1 cells. Moreover, Nrf2 pathway is involved in this process.
Collectively, our and other studies show that LAMPs activate the NF-κB pathway and are proinflammatory. Moreover, our study provides evidence that Nrf2 can regulate the inflammatory reaction and play a negative regulatory role in THP-1 cells. It is possible that there is 'cross-talk' between Nrf2/ARE and NF-κB signaling pathways in response to LAMPs. It provides an original idea to further explore the crosstalk between homeostasis and oxidative clearance and the mechanism underlying inflammation regulation. Understanding this functional relationship should be helpful in establishing effective therapies for inflammatory diseases.
FUNDING
This work was supported by the Foundation of Hunan Provincial Key Laboratory for Special Pathogens Prevention and
